Aug 12 |
BioMarin (BMRN) is an Incredible Growth Stock: 3 Reasons Why
|
Aug 12 |
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
|
Aug 10 |
Piper lists eight defensive biotechs to face market volatility
|
Aug 9 |
BioMarin Pharmaceutical Inc (BMRN): Are Hedge Funds Bullish on This Elliott Management-Approved Stock Now?
|
Aug 7 |
BioMarin Pharmaceutical Second Quarter 2024 Earnings: Beats Expectations
|
Aug 6 |
Rare Disease-Focused BioMarin Narrows Sales Focus, Cuts Cost For Hemophilia A Gene Therapy; Lifts Annual Guidance
|
Aug 6 |
When Product Launches Struggle, Biotech Investors Reward Cost Cuts
|
Aug 6 |
Q2 2024 Biomarin Pharmaceutical Inc Earnings Call
|
Aug 6 |
BioMarin Pharmaceutical Reports Strong Q2 Driven by Voxzogo Sales, RBC Says
|
Aug 6 |
BioMarin (BMRN) Q2 Earnings & Sales Top Estimates, Ups '24 View
|